Rafferty Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $343K | Sell |
18,298
-3,099
| -14% | -$58K | ﹤0.01% | 956 |
|
|
2025
Q1 | $385K | Buy |
+21,397
| New | +$385K | ﹤0.01% | 916 |
|
|
2022
Q3 | – | Sell |
-108,854
| Closed | -$1.23M | – | 1230 |
|
|
2022
Q2 | $1.23M | Buy |
108,854
+74,031
| +213% | +$837K | 0.01% | 584 |
|
|
2022
Q1 | $1.04M | Sell |
34,823
-13,806
| -28% | -$413K | 0.01% | 772 |
|
|
2021
Q4 | $1.29M | Buy |
48,629
+19,079
| +65% | +$506K | 0.01% | 785 |
|
|
2021
Q3 | $1.07M | Sell |
29,550
-11,658
| -28% | -$423K | 0.01% | 795 |
|
|
2021
Q2 | $1.79M | Sell |
41,208
-21,335
| -34% | -$926K | 0.01% | 719 |
|
|
2021
Q1 | $2.14M | Buy |
62,543
+53,637
| +602% | +$1.83M | 0.01% | 603 |
|
|
2020
Q4 | $312K | Sell |
8,906
-18,167
| -67% | -$636K | ﹤0.01% | 799 |
|
|
2020
Q3 | $650K | Buy |
+27,073
| New | +$650K | 0.01% | 647 |
|
|
2019
Q3 | – | Sell |
-28,317
| Closed | -$739K | – | 838 |
|
|
2019
Q2 | $739K | Sell |
28,317
-6,853
| -19% | -$179K | 0.01% | 617 |
|
|
2019
Q1 | $904K | Buy |
+35,170
| New | +$904K | 0.01% | 571 |
|